Companies / Antios Therapeutics
Antios Therapeutics
United States
Antios Therapeutics develops innovative therapies to treat and cure hepatitis B virus and other viral diseases.
Antios Therapeutics, based in United States, has 4 investors on file, among them Aisling Capital, Altium Capital and Avego. Its site was last checked 6 Nov 2026: site answers.
SEC Form D filings
4 filingsFiled by Antios Therapeutics Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
4 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Antios Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Aisling Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/antiostherapeutics.com/investors
# also
GET /v1/companies/antiostherapeutics.com
GET /v1/companies/antiostherapeutics.com/news